Liabilities / Assets
8th percentile
Higher debt load relative to assets than 8% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
8th percentile
Higher debt load relative to assets than 8% of similar nonprofits.
Liabilities / Revenue
30th percentile
Higher debt load relative to revenue than 30% of similar nonprofits.
Net Margin
4th percentile
Higher net margin than 4% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
74th percentile
Faster asset growth than 74% of similar nonprofits.
Revenue Growth
73rd percentile
Faster revenue growth than 73% of similar nonprofits.
Assets
Up$94,409,514
Up $8,522,645 (+9.9%) from 2011
Net Assets
Up$93,425,272
Up $8,328,561 (+9.8%) from 2011
Liabilities
Up$984,242
Up $194,084 (+25%) from 2011
Revenue
Up$4,592,597
Up $558,189 (+14%) from 2011
Expenses
Up$8,190,685
Up $109,265 (+1.4%) from 2011
Net Income
Up-$3,598,088
Up $448,924 (+11%) from 2011
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
As a supporting organization to the Clayton Foundation for Research (Clayton), the organizations primary mission is to fund medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products for the use and benefit of mankind through Claytons other supporting entities.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.